Ronald Kirk Huntsman - Feb 25, 2022 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Stock symbol
VVOS
Transactions as of
Feb 25, 2022
Transactions value $
$408,750
Form type
4
Date filed
2/28/2022, 05:54 PM
Previous filing
Feb 14, 2022
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $409K +125K $3.27* 125K Feb 25, 2022 Common Stock 125K $3.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 125,000 stock options granted on February 25, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through February 25, 2026.